Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Liofilchem Nordics ApS
APS
Active
CVR 44174774
Nordre Fasanvej 215
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2023
2 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
DKK 1,7M
+49% vs 2024
EBITDA margin
100.0%
+700% vs 2024
Equity ratio
57.7%
Financial strength
Net profit 2025
DKK 1,3M
+716% vs 2024
EBITDA — year on year
DKK millions
3M
2M
1M
1M
0M
0M
2024
2M
+200%
2025
Key figures
Annual report 2025
Revenue
DKK 1,7M
+49%
EBITDA
DKK 1,7M
+700%
Net profit
DKK 1,3M
+716%
Total assets
DKK 2,5M
+12%
Equity
DKK 1,5M
+650%
Employees
2
—
Company information
Legal name
Liofilchem Nordics ApS
CVR number
44174774
Legal form
Anpartsselskab
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
3. juli 2023
Share capital
DKK 40.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør.
Company purpose
Selskabets formål er repræsentation og salg af mikrobiologiprodukter.
Contact
Address
Nordre Fasanvej 215
Email
info@liofilchem.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in Frederiksberg
All Denmark companies
Revenue
DKK millions
0M
1M
1M
2M
2M
1M
2024
2M
2025
EBITDA
DKK millions
0M
1M
1M
2M
2M
0M
2024
2M
2025
Income statement
DKK thousands
Item
2024
2025
Revenue
1.107
1.652
Staff expenses
-901
-0
EBITDA
206
1.652
Depreciation & amort.
-0
-0
EBIT
206
1.652
Net financials
-5
-15
Profit before tax
201
1.637
Tax
45
363
Net profit
156
1.273
Balance sheet
DKK thousands
Item
2024
2025
Total assets
2.283
2.547
Equity
196
1.469
Long-term debt
0
0
Short-term debt
2.087
1.078
Total debt
2.087
1.078
Financial ratios
5-year trend
EBITDA margin
100.0%
This company
15.8%
Market median
+533% vs market
2024
2025
Equity ratio
57.7%
This company
38.2%
Market median
+51% vs market
2024
2025
Return on equity
86.7%
This company
18.4%
Market median
+371% vs market
2024
2025
Net profit margin
77.1%
This company
8.1%
Market median
+852% vs market
2024
2025
Asset turnover
0.65×
This company
1.12×
Market median
-42% vs market
2024
2025
Debt / equity
0.73×
This company
0.62×
Market median
+18% vs market
2024
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2023-07-03 – 2024-12-31
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (1)
MG
Mette Gade
Founder
Founder
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Liofilchem S.R.L
Individual
50–66.65%
50–66.65%
2023
Fabio Brocco
Individual
33.33–49.99%
33.33–49.99%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Liofilchem Nordics ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Mette Gade
Founder
0 companies